The Role of Platelet-Rich Plasma in Inducing Musculoskeletal Tissue Healing
- 651 Downloads
Platelet-rich plasma [PRP] has received increasing interest across many musculoskeletal disciplines and has been widely applied clinically to stimulate tissue healing in numerous anatomical regions. The known actions of platelet-derived factors suggest that PRP may have significant potential in the treatment of pathological conditions of cartilage, tendon, ligament, and muscle.
The aim of this manuscript is to review current literature regarding the biology of PRP and the efficacy of using PRP to augment healing of tendon ligament and muscle injuries, as well as early osteoarthritis.
A comprehensive literature review of musculoskeletal applications of PRP was performed, including basic science and clinical studies such as randomized controlled trials, case controlled series, and case series.
The most compelling evidence to support the efficacy of PRP is for its application to tendon damage associated with lateral and medial epicondylitis. Although some promising studies have been reported supporting the use of PRP in osteoarthritis and ligament and muscle injuries, it currently remains unknown whether PRP effectively alters the progression of osteoarthritis or aids the healing of ligament and muscle tissues.
The rationale for the use of PRP to improve tissue healing is strong, but the efficacy for many musculoskeletal applications remains unproven. PRP has been shown to be a safe treatment. A number of questions regarding PRP remain unanswered, including the optimal concentration of platelets, what cell types should be present, the ideal frequency of application, or the optimal rehabilitation regimen for tissue repair and return to full function.
Keywordsplatelet-rich plasma ligament healing osteoarthritis tendon
The authors wish to thank Catherine Hayter, MBBS for the assistance with the analysis of the MRI images included in this manuscript.
Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.
This work was performed at Hospital for Special Surgery.
- 1.Anitua E, Andia I, Ardanza B, Nurden P and Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemos. 2004; 91: 4–15.Google Scholar
- 2.Anitua E, Sanchez M, Nurden AT, Zalduendo MM, De la Fuente M, Azofra J and Andia, I. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology. 2007; 46: 1769–1772.PubMedCrossRefGoogle Scholar
- 3.Arnoczky SP, Caballero O and Yeni YN. Platelet-rich Plasma To Augment Connective Tissue Healing: Making Sense of It All. J Am Acad Orthop Surg. 2010; 18: 445–446.Google Scholar
- 4.Barrett S and Erredge S. Growth Factors For Chronic Plantar Fasciitis? Podiatry Today. 2004; 17: 36–42.Google Scholar
- 6.Carmona J, Arguelles D, Climent F, Prades M, Soler R, Vidal F and Orozco L. Autologous platelet-rich plasma injected intraarticularly diminished synovial effusion and degree of lameness in horses affected with severe joint disease. Annual Scientific Meeting of the European College of Veterinary Surgeons. Lyon. 2005.Google Scholar
- 16.Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, Grasso MA and Panzani I. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac-surgery. Int J Artificial Organs. 1987; 10: 47–50.Google Scholar
- 31.Joyce ME, Jingushi S, Scully SP and Bolander ME. Role of growth factors in fracture healing. Progress Clin Biol Res. 1991; 365: 391–416.Google Scholar
- 34.Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, Fornasari PM, Giannini S and Marcacci M. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010; 18: 472–9.PubMedCrossRefGoogle Scholar
- 44.Peerbooms JC, Sluimer J, Bruijn DJ and Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010; 38: 255–262.PubMedCrossRefGoogle Scholar
- 48.Ranly DM, McMillan J, Keller T, Lohmann CH, Meunch T, Cochran DL Schwartz Z and Boyan BD. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation-A study of immunocompromised mice. J Bone Joint Surg Am. 2005; 87: 2052–2064.PubMedCrossRefGoogle Scholar
- 49.Rodeo SA, Delos D, Williams RJ, Adler RA, Pearle A and Warren RF. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: A prospective randomized clinical study. Under Review, Am J Sports Med, 2011.Google Scholar
- 60.Vogrin M, Rupreht M, Dinevski D, Haspl M, Kuhta M, Jevsek M, Knezevic M and Rozman P. Effects of a Platelet Gel on Early Graft Revascularization after Anterior Cruciate Ligament Reconstruction: A Prospective, Randomized, Double-Blind, Clinical Trial. Europ Surg Res. 2010; 45: 77–85.CrossRefGoogle Scholar
- 66.Zummstein MA Lesbats V, Trojani C and Boileau P. A New Technique of Biologic Augmentation in Repair of Chroni Rotator Cuff Tears using Autologous Platelet Rich Fibrin (PRF): Vascularization Response and Tendon Healing in a Prospective Randomized Trial. ASES Meeting 2010 Abstracts, p. 27.Google Scholar